The Gastroesophageal Junction Adenocarcinoma Therapeutics market is expected to grow at a value of 18% in the forecast period ...

This is the game that TissueCypher is changing. Rather than have physicians make educated guesses about an individual patient ...

is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma. It is characterized histologically by a specialized intestinal metaplasia that replaces the squamous ...

Obesity is associated with a range of disorders that might cause gastroesophageal reflux disease (GERD), such as increased abdominal pressure, impaired gastric emptying, and increased esophageal ...

Barrett's esophagus is a premalignant condition that predisposes to the development of esophageal adenocarcinoma. The carcinogenetic process of Barrett's mucosa progresses through increasing ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving ...

The company also recently published multiple new clinical validation studies to support its quest for reimbursement.

Barrett’s esophagus, which describes changes in the lining of the lower esophagus due to chronic damage from stomach acid, is ...

In the last 40 years, the incidence of esophageal adenocarcinoma has been increasing in the Western world. Barrett's esophagus is found in 5–15% of patients who seek medical care for heartburn ...

BE is the only known precursor to esophageal adenocarcinoma, the most common type of esophageal cancer. 1 Esophageal cancer is one of the fastest-growing cancers in incidence in the United States ...